SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.

Lip, GYH; Nikorowitsch, J; Sehner, S; Becher, N; Bertaglia, E; Blomstrom-Lundqvist, C; Brandes, A; Beuger, V; Calvert, M; Camm, AJ; et al. Lip, GYH; Nikorowitsch, J; Sehner, S; Becher, N; Bertaglia, E; Blomstrom-Lundqvist, C; Brandes, A; Beuger, V; Calvert, M; Camm, AJ; Chlouverakis, G; Dan, G-A; Dichtl, W; Diener, HC; Fierenz, A; Goette, A; de Groot, JR; Hermans, A; Lubinski, A; Marijon, E; Merkely, B; Mont, L; Ozga, A-K; Rajappan, K; Sarkozy, A; Scherr, D; Schnabel, RB; Schotten, U; Simantirakis, E; Toennis, T; Vardas, P; Wichterle, D; Zapf, A; Kirchhof, P (2024) Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. Eur Heart J, 45 (19). pp. 1733-1737. ISSN 1522-9645 https://doi.org/10.1093/eurheartj/ehae225
SGUL Authors: Camm, Alan John

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (2MB) | Preview
Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Keywords: Anticoagulation, Atrial fibrillation, Atrial high-rate episodes, Bleeding, CHA2DS2-VASc score, Device-detected atrial fibrillation, Kidney function, NOAH-AFNET 6, Stroke, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology
Journal or Publication Title: Eur Heart J
ISSN: 1522-9645
Language: eng
Dates:
DateEvent
14 May 2024Published
9 April 2024Published Online
26 March 2024Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
AA/18/2/34218British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
FKZ 81X2800182German Center for Cardiovascular ResearchUNSPECIFIED
UNSPECIFIEDDaiichi Sankyo Europehttp://dx.doi.org/10.13039/501100022274
633196European UnionUNSPECIFIED
847770European UnionUNSPECIFIED
965286European UnionUNSPECIFIED
Ki 509167694German Research FoundationUNSPECIFIED
81Z0710116Deutsches Zentrum für Herz-Kreislaufforschunghttp://dx.doi.org/10.13039/100010447
81Z0710110Deutsches Zentrum für Herz-Kreislaufforschunghttp://dx.doi.org/10.13039/100010447
UNSPECIFIEDLeducq FoundationUNSPECIFIED
01-002-2022-0118Dutch Heart FoundationUNSPECIFIED
PubMed ID: 38591192
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116428
Publisher's version: https://doi.org/10.1093/eurheartj/ehae225

Actions (login required)

Edit Item Edit Item